Müller W E, Böhm M, Batel R, De Rosa S, Tommonaro G, Müller I M, Schröder H C
Institut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, Germany.
J Nat Prod. 2000 Aug;63(8):1077-81. doi: 10.1021/np000003p.
Among all metazoan phyla, sponges are known to produce the largest number of bioactive compounds. However, until now, only one compound, arabinofuranosyladenine, has been approved for application in humans. One major obstacle is the limited availability of larger quantities of defined sponge starting material. Recently, we introduced the in vitro culture of primmorphs from Suberites domuncula, which contain proliferating cells. Now we have established the primmorph culture also from the marine sponge Dysidea avara and demonstrate that this special form of sponge cell aggregates produces avarol, a sesquiterpenoid hydroquinone, known to display strong cytostatic activity especially against mammalian cells. If dissociated sponge cells are transferred into Ca(2+)- and Mg(2+)-containing seawater, they form after a period of two to three days round-shaped primmorphs (size of 1 to 3 mm). After longer incubation, the globular primmorphs fuse and form meshes of primmorphs that adhere to the bottom of the incubation chamber. Later, during incubation, freely floating mesh-primmorphs are formed. No bacterial rRNA could be detected in the primmorphs. We were able to prove that the primmorphs produce avarol. Levels (1.4 microg of avarol/100 microg of protein) close to those identified in specimens from the field (1.8 microg/100 microg) are reached. Avarol was extracted from the cells with EtOAc and subsequently purified by HPLC. The identification was performed spectrophotometrically and by thin-layer chromatography. Single cells apparently do not have the potency to produce this secondary metabolite. It is concluded that the primmorph model is a suitable system for the synthesis of bioactive compounds in vitro.
在所有后生动物门中,已知海绵产生的生物活性化合物数量最多。然而,到目前为止,只有一种化合物,即阿拉伯呋喃糖基腺嘌呤,已被批准用于人类。一个主要障碍是难以获得大量确定的海绵起始材料。最近,我们引入了来自多孔动物Suberites domuncula的原形体的体外培养,其中含有增殖细胞。现在我们也从海洋海绵Dysidea avara建立了原形体培养,并证明这种特殊形式的海绵细胞聚集体产生avarol,一种倍半萜对苯二酚,已知其具有很强的细胞抑制活性,尤其是对哺乳动物细胞。如果将解离的海绵细胞转移到含有Ca(2+)和Mg(2+)的海水中,它们在两到三天后会形成圆形的原形体(大小为1至3毫米)。经过更长时间的孵育,球形原形体融合并形成附着在培养室底部的原形体网。后来,在孵育过程中,形成了自由漂浮的网状原形体。在原形体中未检测到细菌rRNA。我们能够证明原形体产生avarol。其水平(1.4微克avarol/100微克蛋白质)接近在野外样本中鉴定出的水平(1.8微克/100微克)。用乙酸乙酯从细胞中提取avarol,随后通过高效液相色谱法进行纯化。通过分光光度法和薄层色谱法进行鉴定。单细胞显然没有产生这种次生代谢物的能力。得出的结论是,原形体模型是体外合成生物活性化合物的合适系统。